论文信息 - One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment - 字舞流文

One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment

R. Wells | A. Bosi | A. Gaya | R. Brodsky | J. Lee | S. Langemeijer | K. Usuki | R. Latour | A. Kulasekararaj | A. Röth | C. Piatek | A. Hill | M. Ogawa | F. González-Fernández | S. Ortiz | E. Gutierrez | Lindsay D Mitchell | Ji Yu